Respiratory distress syndrome (RDS) is a serious condition characterized by the inability of the lungs to provide adequate oxygenation to the body's tissues, leading to respiratory failure. It is most commonly observed in premature infants due to surfactant deficiency, but can also occur in adults, often referred to as acute respiratory distress syndrome (ARDS). The condition manifests as a rapid onset of breathing difficulties and requires prompt medical intervention to prevent severe complications or mortality.

The risk factors for RDS vary between infants and adults. In neonates, prematurity, low birth weight, and maternal diabetes are significant risks, while for adults, factors such as pneumonia, sepsis, trauma, and inhalation of harmful substances can precipitate ARDS. Genetic predisposition and underlying lung disease can also increase vulnerability to respiratory distress.

Symptoms of RDS typically include labored or rapid breathing, grunting sounds during exhalation, retractions of the chest wall, and cyanosis, which indicates low oxygen levels. In adults, the symptoms may manifest as severe shortness of breath, rapid breathing, and a sense of impending doom, often accompanied by a cough or fever depending on the underlying cause. Prompt recognition of these symptoms is critical for effective intervention.

Respiratory distress syndrome (RDS) primarily occurs due to a deficiency of surfactant, a substance that helps keep the alveoli in the lungs open, leading to respiratory failure. In infants, particularly premature ones, RDS is common as their lungs may not be fully developed. In adults, it can result from trauma, pneumonia, sepsis, or exposure to harmful substances, which can lead to acute respiratory distress syndrome (ARDS). Other contributing factors may include genetic predispositions and underlying health conditions affecting lung function.

Diagnosis of respiratory distress syndrome is typically based on clinical evaluation and respiratory assessment, supported by imaging studies such as chest X-rays or CT scans that reveal characteristic patterns of lung infiltration. Blood tests including arterial blood gas analysis help assess oxygenation and carbon dioxide levels, while identifying underlying causes may involve cultivations or other specific tests. Timely diagnosis is essential to initiate appropriate treatment protocols.

The management of respiratory distress syndrome involves supportive care, including supplemental oxygen therapy to maintain adequate blood oxygen levels. For infants, surfactant replacement therapy can be administered to improve lung function, while adults may require mechanical ventilation to assist with breathing. Addressing underlying causes, such as treating pneumonia or managing sepsis, is essential for improving outcomes, and ongoing monitoring and supportive measures are critical throughout the treatment process.

Preventive strategies for respiratory distress syndrome in premature infants include administering corticosteroids to pregnant women at risk of preterm delivery, which helps accelerate fetal lung maturity and surfactant production. In adults, preventive measures against ARDS include managing underlying lung diseases, ensuring proper ventilation during high-risk procedures, and minimizing exposure to harmful substances or conditions that can impair lung function. Early recognition and management of respiratory infections and other risk factors are also crucial in reducing incidence.